Clinical Trial: Ivabradine for Long-Term Effects of COVID-19 With POTS Cohort
Study Status: Completed
Recruit Status: RECRUITING
Condition: Long Haul COVID
Study Type: INTERVENTIONAL
Official Title: Comparative Cohort Study of Post-acute COVID-19 Infection With a Nested, Randomized Controlled Trial of Ivabradine for Those With Postural Orthostatic Tachycardia Syndrome.
Brief Summary:
The purpose of the study is three-fold.The primary aim is to identify the proportion of Long-Haul COVID (LHC) and non-LHC volunteers with relevant symptoms actually have postural orthostatic tachycardia syndrome (POTS).The second is to determine benefit of ivabradine treatment.Ivabradine is a drug approved to treat tachycardia in persons with heart failure.The third is to characterize risk factors and outcomes among volunteers with and without LHC.This will include comparison with COVID-19-positive individuals who…
Read more